Wendy Davis

Prof. Wendy Davis

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
WDWendy Davis
Wendy Davis
MKMatthew Knuiman
Matthew Knuiman
PKPeter Kendall
Peter Kendall
VGValerie Grange
Valerie Grange
Timothy M. E. DavisTimothy M. E. Davis
Timothy M. E. Davis
OBJECTIVE—To examine prospectively the relationship between diabetes, glycemic control, and spirometric measures. RESEARCH DESIGN AND METHODS—From a community-based cohort, 495 Europid (i.e., of European descent) patients with type 2 diabetes who had no history of pulmonary disease underwent baseline spirometry between 1993 and 1994. A subset of 125 patients was restudied a mean of 7.0 years later. The main outcome measures included forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), vital capacity (VC), and peak expiratory flow (PEF) corrected for body temperature, air pressure, and water saturation and were expressed either in absolute terms or as percentage-predicted value for age, sex, and height. RESULTS—Mean percentage-predicted values of each spirometric measure were decreased >10% in the whole cohort at baseline and absolute measures continued to decline at an annual rate of 68, 71, and 84 ml/year and 17 l/min for FVC, FEV1, VC, and PEF, respectively, in the 125 prospectively studied patients. Declining lung function measures were consistently predicted by poor glycemic control in the form of a higher updated mean HbA1c, follow-up HbA1c, or follow-up fasting plasma glucose. In a Cox proportional hazards model, decreased FEV1 percentage-predicted value was an independent predictor of all-cause mortality. CONCLUSIONS—Reduced lung volumes and airflow limitation are likely to be chronic complications of type 2 diabetes, the severity of which relates to glycemic exposure. Airflow limitation is a predictor of death in type 2 diabetes after adjusting for other recognized risk factors.

14 August 2012 in Diabetologia
Verified
Journal Article
Closed access
PDF file
JBJ. R. W. Brownrigg
J. R. W. Brownrigg
JDJ. Davey
J. Davey
PHP. J. Holt
P. J. Holt
WDWendy Davis
Wendy Davis
MTM. M. Thompson
M. M. Thompson
RHR. J. Hinchliffe
R. J. Hinchliffe

1 March 2006 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
PNPaul E. Norman
Paul E. Norman
WDWendy Davis
Wendy Davis
DBDavid Bruce
David Bruce
Timothy M. E. DavisTimothy M. E. Davis
Timothy M. E. Davis
OBJECTIVE—The purpose of this study was to examine the natural history of peripheral arterial disease (PAD) complicating type 2 diabetes, in particular the influence of PAD on the risk of cardiac death and the adequacy of PAD risk factor management. RESEARCH DESIGN AND METHODS—The Fremantle Diabetes Study (FDS) was a prospective community-based observational study of diabetic patients recruited between 1993 and 1996. The present sample comprised the 1,294 FDS type 2 diabetic patients and a subgroup of 531 of these who had valid data at baseline and five or more subsequent consecutive annual reviews. Assessments consisted of a range of clinical and biochemical variables including the ankle/brachial index (ABI). PAD was defined as an ABI ≤0.90 at two consecutive reviews or any PAD-related lower-extremity amputation. RESULTS—The prevalence of PAD at study entry was 13.6% and the incidence of new PAD was 3.7 per 100 patient-years. Both prevalent and incident PAD was strongly and independently associated with increasing age, systolic blood pressure, total serum cholesterol, and especially smoking. Risk factor management improved but remained suboptimal during follow-up. An ABI of ≤0.90 was independently associated with an increased risk of cardiac death of 67%. CONCLUSIONS—Measurement of the ABI is a simple means of identifying PAD in diabetic patients. PAD is common in diabetic patients and predicts cardiac death. These data further support the role of regular screening for PAD in diabetes so that intensive management of vascular risk factors can be pursued.

3 July 2009 in Diabetologia
Verified
Journal Article
Closed access
PDF file
DBDavid Bruce
David Bruce
WDWendy Davis
Wendy Davis
GCG. P. Casey
G. P. Casey
RCR. M. Clarnette
R. M. Clarnette
SBS. G. A. Brown
S. G. A. Brown
Timothy M. E. DavisTimothy M. E. Davis
Timothy M. E. Davis

11 January 2008 in Diabetologia
Verified
Journal Article
Closed access
PDF file
Timothy M. E. DavisTimothy M. E. Davis
Timothy M. E. Davis
BYB. B. Yeap
B. B. Yeap
WDWendy Davis
Wendy Davis
DBDavid Bruce
David Bruce

1 April 2019 in Critical Care Medicine
Verified
Journal Article
Open access
ABAnnika Reintam Blaser
Annika Reintam Blaser
ARAdrian Regli
Adrian Regli
BKBart De Keulenaer
Bart De Keulenaer
EKEdward J. Kimball
Edward J. Kimball
LSLiis Starkopf
Liis Starkopf
JSJoel Starkopf
Joel Starkopf
Objectives: To identify the prevalence, risk factors, and outcomes of intra-abdominal hypertension in a mixed multicenter ICU population. Design: Prospective observational study. Setting: Fifteen ICUs worldwide. Patients: Consecutive adult ICU patients with a bladder catheter. Interventions: None. Measurements and Main Results: Four hundred ninety-one patients were included. Intra-abdominal pressure was measured a minimum of every 8 hours. Subjects with a mean intra-abdominal pressure equal to or greater than 12 mm Hg were defined as having intra-abdominal hypertension. Intra-abdominal hypertension was present in 34.0% of the patients on the day of ICU admission (159/467) and in 48.9% of the patients (240/491) during the observation period. The severity of intra-abdominal hypertension was as follows: grade I, 47.5%; grade II, 36.6%; grade III, 11.7%; and grade IV, 4.2%. The severity of intra-abdominal hypertension during the first 2 weeks of the ICU stay was identified as an independent predictor of 28- and 90-day mortality, whereas the presence of intra-abdominal hypertension on the day of ICU admission did not predict mortality. Body mass index, Acute Physiology and Chronic Health Evaluation II score greater than or equal to 18, presence of abdominal distension, absence of bowel sounds, and positive end-expiratory pressure greater than or equal to 7 cm H2O were independently associated with the development of intra-abdominal hypertension at any time during the observation period. In subjects without intra-abdominal hypertension on day 1, body mass index combined with daily positive fluid balance and positive end-expiratory pressure greater than or equal to 7 cm H2O (as documented on the day before intra-abdominal hypertension occurred) were associated with the development of intra-abdominal hypertension during the first week in the ICU. Conclusions: In our mixed ICU patient cohort, intra-abdominal hypertension occurred in almost half of all subjects and was twice as prevalent in mechanically ventilated patients as in spontaneously breathing patients. Presence and severity of intra-abdominal hypertension during the observation period significantly and independently increased 28- and 90-day mortality. Five admission day variables were independently associated with the presence or development of intra-abdominal hypertension. Positive fluid balance was associated with the development of intra-abdominal hypertension after day 1.